The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome*

Medicine (United States)

Volumn 50, Issue 5, 1971, Pages 357-420

  Ward, Harry P ^a   Block, Matthew H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANDROGEN; BUSULFAN; CORTICOSTEROID; PHOSPHORUS; URIC ACID;

ADULT; ANEMIA; ANIMAL; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING TEST; BONE MARROW; DRUG POTENTIATION; FEMALE; HEMATOPOIESIS; HEMOLYSIS; HUMAN; INFECTION; LEUKEMIA; LEUKOCYTE; LEUKOCYTOSIS; LIVER; LIVER FUNCTION TEST; MALE; MORTALITY; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; OSTEOSCLEROSIS; PATHOLOGY; POLYCYTHEMIA VERA; PORTAL HYPERTENSION; RADIOGRAPHY; REVIEW; SPLEEN; SPLENECTOMY; THROMBOCYTOPENIA;

ADRENAL CORTEX HORMONES; ALKALINE PHOSPHATASE; ANDROGENS; ANEMIA; ANIMAL; BLOOD CELL COUNT; BLOOD COAGULATION TESTS; BONE MARROW; BUSULFAN; DRUG SYNERGISM; FEMALE; HEMATOPOIESIS; HEMOLYSIS; HUMAN; HYPERTENSION, PORTAL; INFECTION; LEUKEMIA; LEUKOCYTES; LEUKOCYTOSIS; LIVER; LIVER FUNCTION TESTS; MALE; MIDDLE AGE; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDERS; OSTEOSCLEROSIS; PHOSPHORUS ISOTOPES; POLYCYTHEMIA VERA; SPLEEN; SPLENECTOMY; THROMBOCYTOPENIA; URIC ACID;

EID: 0015115075     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/00005792-197109000-00001     Document Type: Article

References (359)

1. Ackerman, G. A., Grasso, J. A. and Knouff, R. A.: Erythropoiesis in the mammalian embryonic liver as revealed by election microscopy. Lab. Invest., 10: 787, 1961.
2. Alfejew, S.: Die embryonale histogenese der zellformen des lockeren bindegewebes der Saugetiere. Folia Haemat. Arch., 30: 111. 1924.
3. Anagnostu, J. L.: Beitrag zum Studium de systematischen Osteosklcrosen. Folia Haemat., 50: 70, 1933.
4. Andersen, B. and Lund, T.: Osteosclerotic anemia in a boy of 17 months. Acta Path. Microbiol. Scand, 20: 425, 1943.
5. Anderson, R. E., Hoshino, T. and Yamamoto. T.: Myelofibrosis with myeloid metaplasia in survivors of the atomic bomb in Hiroshima. Ann. Intern. Mod., 60: 1, 1964.
6. Andre, J., Schwartz, R. and Dameshek, W.: Tuberculosis and myelosclerosis with myeloid metaplasia. J.A.M.A., 178: 1169, 1961.
7. Andrew, W.: Comparative Hematology. Grune and Stratton, New York, 1965.
8. Apitz, D.: Zur histogenese der knochenveränderungen bei osterosklcrotischer anamie. Verh. d. deutsch, path. Ges., 81: 486, 1939.
9. Argano, S. A. P., Tobin, M. S. and Spain, D. M.: Experimental induction of myelofibrosis with myeloid metaplasia. Blood, 33: 851, 1969.
10. Asher, R.: Polyoythaemia, myelofibrosis, splenectomy, myeloid leukosis and polycythaemia. Proc. Roy. Soc. Med., 48: 539, 1955.
11. Askanazy, M.: Ueber extrauterine bildung von blutzellen un der leber. Verh. d. deutsch. path. Ges., 7: 58, 1904.
12. Assmann, H.: Beiträge zur osteosklerotischen anamie. Beitr. Path. Anat., 41: 565, 1907.
13. Athens, J. W., Haab, O. P., Raab, S. O., Boggs, D. R., Ashenbrucker, H., Cartwright, G. E. and Wintrobe, M. M.: Leukokinetic studies. XL Blood granulocyte kinetics in polycythemia vera, infection, and myelofibrosis. J. Clin. Invest., 44: 778, 1965.
14. Baikie, A. G., Cunningham, T. A. and McAlpine, S. G.: Thrombocythaemia and thrombocytosis in the myeloproliferative syndromes. Scot. Med. J., 3: 26, 1958.
15. Baldini, M., Fudenberg, H., Fukutake, K., and Damashek, W.: The anemia of the Di Guglielmo Syndrome. Blood, 14: 334, 1959.
16. Ballin, M. and Morse, P. F.: Myelophthisic splenomegaly. J.A.M.A., 89: 1671, 1927.
17. Barnes, W. A. and Sisman, I. E.: Myeloid leukemia and non-malignant extramedullary myelopoiesis in mice. Amer. J. Cancer, 37: 1, 1939.
18. Bartos, H., Desforges, J. F. and Moloney, W. C.: Red cell enzymes in the anemia of myelofibrosis. Ann. Intern. Med., 68: 533, 1968.
19. Bastrup-Madsen, P.: Myelosclerotic anemia. Report of a case. Acta Radiol., 37: 189, 1952.
20. Beattie, J. W. and Withey, J. L.: Polyoythaemia, leukoerythroblastosis and myelosclerosis. Brit. Med. J., 2: 414, 1953.
21. Better, O., Brandstaetter, S., Padeh, B. and Biaim, G.: Myeloid metaplasia: Clinical, laboratory and cytogenetic observations. Israel Med. J., 28: 162, 1964.
22. Beyreder, J. and Rieder, H.: Zur diagnostik und Klinik der Osteomyelosklerose. Acta Haemat., 16: 299, 1956.
23. Bierman, H. R., Marshall, G. J., Kelly, K. H. and Byron, R. L.: Leukapheresis in man. III. Hematologic observations in patients with leukemia and myeloid metaplasia. Blood, 21: 164, 1963.
24. Birkner, R. and Frey, J. G.: Uber die rontgenologrischen haematologishen und pathologisch-anatomischen Grundlagen der anaemia leuco-erythroblastica mit Myelosklerosis vom Vaughn. Fort. a.d. Geb. d. Rontg, 77: 287, 1952.
25. Bishop, C, Garner, W. and Talbott, J. H.: Pool size, turnover rate, and rapidity of equilibration of injected isotopic uric acid in normal and pathological subjects. J. Clin. Invest., 30: 879, 1951.
26. Black-Schaffer, B. and Stoddard, L. D.: Panmyelosis and chronic granulocytic leukemia. Amer. J. Path., 29: 413, 1953.
27. Block, M.: An experimental analysis of hematopoiesis in rat yolk sac. Anat. Rec, 96: 289 1946.
28. Block, M.: The influence of intraocular transplantation upon the development of the embryonic liver of the rat. Anat. Rec, 103: 9, 1949.
29. Block, M.: Erythropoiesis in the embryonic nervous system of the rat. Blood, 4- H 56, 1949.
30. Block, M.: Studies on the blood and bloodforming tissues of the newborn opossum. I. Normal development. Ergebnisse der Anatomie und Entwicklungs Geschichte., 37: 237, 1964.
31. Block, M., Brown, J. and Smaller, V.: An adaptation of the Maximow Technique for preparation of sections of hematopoietic tissues. J. Lab. Clin. Med., 42: 145, 1953.
32. Block, M. and Jacobson, L. O.: Splenic puncture. J.A.M.A., 142: 641, 1950.
33. Block, M. and Jacobson, L. O.: Myeloid metaplasia. J.A.M.A., 143: 1390, 1950.
34. Block, M., Jacobson, L. O. and Bethard, W. F.: Preleukemie acute human leukemia. J.A.M.A., 152: 1018, 1953.
35. Bloom, W.: The embryogenesis of mammalian blood. Handbook of Hematology. Vol. 2, ed. by Downey, H., Paul B. Hoeber, Inc., New York, N.Y. 1938.
36. Bloom, W., Bloom, M. A. and McLean, F. C: Calcification and ossification. Medullary bone changes in the reproductive cycle of female pigeons. Anat. Rec., 81: 443, 1941.
37. Blumenthal, R.: Sur l'onigine myelogene de la polycythemic vraie. Arch, de Méd. Exper. et d'Anat. Path., 19: 697, 1907.
38. Bonechi, I.: Ultrastructural alterations of the blood platelets in a case of osteomyelosclerosis with thrombocythemia (IT). Minerva Med., 56: 1556, 1965.
39. Bothwell, T. H., Hurtado, A. V., Donohue, D. M. and Finch, C. A.: Erythrokinetics. IV. The plasma iron turnover as a measure of erythropoiesis. Blood, 12: 409, 1957.
40. Böttiger, L. E. and Hellström, O.: Erythroblastomatosis. Acta Haemat., 16: 329, 1956.
41. Bouroncle, B. A. and Doan. C. A.: Myelofibrosis. Clinical, hematologic and pathologic study of 110 patients. Amer. J. Med. Sci., 243: 697, 1962.
42. Bousser, J.: Les splénomégalies myeloides de l'adulte. La Revue du Practicicn, 4: 1383. 1954.
43. Bousser, J. and Savoie, J. C: Fréquence méconnue de l'ostéosclérose au cours de erythroblastose chronique de l'adulte (ses aspects radiologiques et anatomiques). Le Sang, 22: 613. 1951.
44. Bousser, J. and Savoie, J. C: Les splénomégalies myéloides de l'adulte. Le Sang, 24: 772, 1953.
45. Bowdler, A. J. and Prankerd, T. A. J.: Primary myeloid metaplasia. Brit. Med. J., 1: 1352, 1961.
46. Bowen, P. and Lee. C. S.: Ph-1 chromosome in the diagnosis of chronic myeloid leukemia: Report of a case with features simulating myelofibrosis. Bull. Hopkins Hosp., 113: 1, 1963.
47. Branemark, P. I. and Breine, U.: Formation of bone marrow in isolated segment of rib periosteum in rabbit and dog. Blut., 10: 236, 1964.
48. Brannan, D.: Extramedullary hematopoiesis in anemias. Bull. Hopkins Hosp., 41: 104, 1927.
49. Brewster, H. H. and Wollenman. O. J.: Myeloid metaplasia of the spleen with acute hemolytic anemia. New Eng. J. Med., 227: 822, 1942.
50. Brody, J. E., Beizer, L. H. and Schwartz, S.: Multiple myeloma and the myeloproliferative syndrome. Amer. J. Med., 36: 135, 1964.
51. Brugsch, H.: Persistierende thrombocythämie und leukämie nach milzentfernung. Folia Haemat., 49: 454, 1933.
52. Brunner, H. E.: Die osteomyelofibrose. Acta Haemat., 34: 257, 1965.
53. Bukh, H. and With, T. K.: Spleneetomy in chronic nonleukemic myeloid splenomegaly with report of a case with osteosclerosis. Acta Chir. Scand., 92: 507, 1945.
54. Burston, J. and Pinniger, J. L.: The reticulin content of bone marrow in haematological disorders. Brit. J. Haemat., 9: 172, 1963.
55. Carpenter, G. and Flory, C. M.: Chronic nonleukemic myelosis. Arch. Intern. Med., 67: 489, 1941.
56. Cartwright, G. E., Athens, J. W., Haab, O. P., Raab, S. O., Boogs, D. R. and Wintrobe, M. M.: Blood granulocyte kinetics in conditions associated with granulocytosis. Ann. N.Y. Acad. Sci., 113: 963, 1964.
57. Cartwright, G. E., Finch, C. A., Loeb, V., Moore, C. V., Singer, K. and Dameshek, W.: Panels in therapy. II. Spleneetomy in myeloid metaplasia with myelosclerosis. Blood, 10: 550,1955.
58. Cauchie, C, Denolin-Reubens, R. and Dustin, P., Jr.: Hypertrophie psendotumorale de mesentere dans un cas de myelosclerose. Rev. d'Hemat., 13: 422, 1958.
59. Chanarin, I., Mollin, D. L. and Anderson, B. B.: Folic acid deficiency and the megalo-blastic anemias. Proc. Roy. Soc. Med., 51: 757, 1958.
60. Chapman, E. M.: Osteosclerotic anemia. Amer. J. Med. Sci., 185: 171, 1933.
61. Chevallier, P.: Les splenomegalies myeloides et leurs formes complexes. Le Sang, 20: 112, 1949.
62. Churg, J. and Wachstein, M.: Osteosclerosis, myelofibrosis and leukemia. Amer. J. Med. Sci., 207: 141. 1944.
63. Clinicopathologic Conference. Ascites and Myelofibrosis. ed. by Recent, L. and Hartroft, W. C. Amer. J. Med., 31: 124, 1961.
64. Close, A. S., Taira, Y. and Cleveland, D. A.: Spinal cord compression due to extramedullary hematopoiesis. Ann. Intern. Med., 48: 421. 1958.
65. Cohen, S. M.: Chronic myelogenous leukemia with myelofibrosis. Four years after autoimmune hemolytic anemia. Arch. Intern. Med., 119: 620. 1967.
66. Cook, J. E. Franklin, J. W. Hamilton, H. E. and Fowler, W. M.: Syndrome of myelofibrosis. A.M.A. Arch. Intern. Med., 91: 704, 1953.
67. Corr. W. P. Kyle, W. P. and Bowie, E. J.: Hematologic changes in tuberculosis. Amer. J. Med. Sci., 248: 709. 1964.
68. Crail, H. W. Alt, H. L. and Nadler, W. H.: Myelofibrosis associated with tuberculosis- a report of four cases. Blood, 3: 1426, 1948.
69. Croft, C. R.: Compound disturbance of the bone marrow (the myeloproliferative disorders). Lancet, 2: 1332, 1956.
70. Croizat, P. Guichard, A., Creyssel, R. and Normand, S.: A propos des réactions osseuses dans les myéloses aleucémiques. Le Sang, 24: 804, 1953.
71. Croizat, P., Revol, L., Morel, P., Mouriquand, C. and Drapier, Mme.: A proposde 42 cas cliniques de réticulomyélose aleucémique essentielle. Le Sang, 29: 346,1958.
72. Crosby, W. H.: Indications for splenectomy. Hospital Practice, Aug. 28,1967.
73. Dacie, J. V.: The Hemolytic Anemias, Part III. Secondary or Symptomatic Haemolytic Anemias. Grune and Stratton, Inc., New York, 1967.
74. Dagradi, A. E., Siemsen, J. and Brook, J.: Bleeding esophageal varices in myelofibrosis. Amer. J. Gastroent., 44: 536, 1965.
75. Dameshek, W.: Some speculations on the myeloproliferative syndromes. Blood, 6: 372, 1951.
76. Dameshek, W., Granville, N. B. and Rubio, F., Jr.: Therapy of the myeloproliferative disorders with Myleran. Ann. N.Y. Acad. Sci., 68: 1001, 1958.
77. Dameshek, W. and Gunz, F.: Leukemia. 2nd Ed., Grune and Stratton, New York, 1964.
78. Damon, A. and Holub, D. A.: Host factors in polycythemia vera. Ann. Intern. Med., 49:: 43, 1958.
79. Didisheim, P. and Bunting, D.: Abnormal platelet function in myelofibrosis. Amer. J. Clin. Path., 45:: 566, 1966.
80. Dieterick, H.: Studien über extramedullare blutbildung bie chirungischen erkrankurgen. Arch. Klin. Chiv., 134: 166, 1925.
81. DiGuglielmo, G.: Les maladies erythremiques. Rev. d'hemat., 1: 23, 1936.
82. DiGuglielmo, G.: Erythroleukemia. Scientia Med. Italica, 3: 14, 1954.
83. Donhauser, J. L.: The human spleen as an haematoplastic organ, as exemplified in a case of splenomegaly with sclerosis of the bone marrow. J. Exp. Med., 10: 559, 1908.
84. Downey, H. and Nordland, M.: Hematologic and histologic study of a case of myeloid megakaryocytic hepatosplenomegaly. Folia Haemat., 62: 1, 1939.
85. Ducuing, J., Miletzky, O. and Marqués, P.: Document pour l'étude de l'osteose cancereuse diffuse et de l'anemia "myelogenetique. Press Med., 46: 1693, 1937.
86. Ecker, J. A., McKittrick, J. E. and Failing, R. M.: Thrombosis of the hepatic veins. Amer. J. Gastroent., 46: 429, 1966.
87. 59. Acta Haemat., 9: 73,1953.
88. Elveback, L.: Actuarial estimate of survivorship in chronic disease. J. Amer. Stat. Assn., 53: 420, 1958.
89. Engelbreth-Holm, J.: Spontaneous and Experimental Leukemia in Animals. Oliver and Boyd, Ltd., London, 1942.
90. Engell, H. C: Myelosclerosis. Acta. Med. Scand., 129: 371,1947.
91. Erf, L. A. and Herbut, P. A.: Primary and secondary myelofibrosis (a clinical and pathological study of 13 cases of fibrosis of the bone marrow). Ann. Intern. Med., 21: 863, 1944.
92. Favre, M., Crozier, P. and Guichard, A.: La myélose aleucémique mégacaryocytaire. Ann. Med., 35: 5,1934.
93. Filmanowicz, E. and Gurney, C. W.: Studies on erythropoiesis XVI. Response to a single dose of erythropoietin in polycythemic mouse. J. Lab. Clin. Med., 57: 65, 1961.
94. Finch, S. C. and Ross, J. F.: The significance of plasma iron turnover. J. Clin. Invest., 31: 624, 1952.
95. Fishman, N. and Ballinger, W. F.: Splenectomy for agnogenic myeloid metaplasia and myelofibrosis. Arch. Surg., 90: 240, 1965.
96. Fitzgerald, P. H., Adams, A. and Gunz, F. W.: Chronic granulocytic leukemia and the Philadelphia chromosome. Blood, 21: 183, 1963.
97. Fliedner, T. M., Cronkite, E. P. and Killmann, S. A.: Granulocytopoiesis II. Emergence and pattern of labeling of neutrophilic granulocytes in humans. Blood, 24: 683, 1964.
98. Forrester, R. H. and Louro, J. M.: Philadelphia chromosome abnormality in agnogenic myeloid metaplasia. Ann. Intern. Med., 64: 622,1966.
99. Forshaw, J., Harwood, L. and Weatherall, D. J.: Folic-acid deficiency and megaloblastic erythropoiesis in myelofibrosis. Brit. Med. J. 1: 671, 1964.
100. Foussereau, S., Oberling, F. and Rousselot, P.: Demonstration of Megakaryocytes in the peripheral blood of patients with megakaryocytic aleukemic myelosis (Fr.). Ann. Anat. Path., 9: 439, 1964.
101. Fresen, O.: Die Retothelialen Hämoblastosen. Virch. Arch. path. Anat., 323: 312, 1953.
102. Frick, P. G.: Primary thrombocythemia. Helv. Med. Acta, 35: 20,1970.
103. Fruhling, L., Maurer, C. and Roger, S.: Forme hémorragipare aigue thrombopénique de la myélose aleucémique mégacaryocytaire. Le Sang, 24: 62,1953.
104. Gahrton, G., Nordén, A. and Stahlberg, K. G.: Cytochemical investigations and serum vitamin B12 determination in a case of erythroleukaemia. Acta Med. Sc, 171: 243, 1962.
105. Gall, E. A.: Benzene poisoning with bizarre extramedullary hematopoiesis. Arch. Path., 25: 315, 1938.
106. Gardner, F. H. and Pringle, J. C, Jr.: Androgens and erythropoiesis II. Treatment of myeloid metaplasia. New Eng. J. Med., 264: 103, 1961.
107. Giblett, E. R., Coleman, D. H., Pirzio-Biroli, G., Donohue, D. M., Motulsky, A. G. and Finch, C. A.: Erythrokinetics: Quantitative measurements of red cell production and destruction in normal subjects and patients with anemia. Blood, 11: 291,1956.
108. Giegler, I.: Osteomyelosklerose and intravitale Knochenbiopsie. Folia Haemat., 81: 206, 1964.
109. 12-binding capacity in myeloproliferative disease. Ann. Intern. Med., 71: 719, 1969.
110. Gilbert, H. S. and Wasserman, L. R.: Hemorrhage in surgery in myelofibrosis, multiple myeloma, leukemia and lymphomas. Ann. N.Y. Acad. Sci., 116: 169,1964.
111. Gilmour, J. R.: Normal haemopoiesis in intrauterine and neonatal life. J. Path. Bact., 52: 25 1941.
112. Glasser, IT. M. and Walker, R. I.: Transitions among the myeloproliferative disorders. Ann. Intern. Mod., 11: 285, 1969.
113. Goh. K. and Swisher, S. N.: Specificity of the Philadelphia chromosome. Ann. Intern. Med., 61: 609, 1964.
114. Goldschmid, E. and Isaac, S.: Endothelhyperplasie als Systemerkrankung des hämato-poetischen Apparates. Deutsch. Arch. J. Klin. Med., 138: 291, 1922.
115. Goswitz, F., Lee, G. R., Cartwright, G. E. and Wintrobe, M. M.: Erythrocyte reduced glutathione, glucose-6-phosphate dehydrogenase and 6-phosphogluconic dehydrogenase in patients with myelofibrosis. J. Lab. Clin. Med., 67: 615, 1966.
116. 12metabolism: Relation to hypo- and hyperleukocytic states and leukocyte turnover. J. Clin. Invest., 45: 1016,1966.
117. Green, T. W., Conley, C. L., Ashburn, L. L. and Peters, H. R.: Splenectomy for myeloid metaplasia of the spleen. New Eng. J. Med., 248: 211, 1953.
118. Gross, S. and Marymount, J. H.: Extramedullary hematopoiesis and metastatic carcinoma in the spleen. Amer. J. Clin. Path., 40: 194, 1963.
119. Gruber, G. B.: Die Leber bei Erkrankungen des blut-und lymphbildenden gewebsapparates, in Handbuch der speziellen pathologischen. Anatomie und Histologie, ed. Henke, F. and Lubarsch, O., Berlin, J. Springer, 5: 631, 1930.
120. Guinon, L. and Simon, R. G.: Sur uncas d'anemie infantile pseudoleucemique. Bull. Soc. Pediat. de Paris, 11: 16, 1909.
121. Gulland, G. L. and Goodall, A.: Pernicious anemia: A histological study of seventeen cases. J. Path. Bact., 10: 125, 1905.
122. Gunz, F. W.: Hemorrhagic thrombocythemia: A critical review. Blood, 15: 706, 1960.
123. Gutman, A. B. and Yu, T. F.: Secondary gout. Ann. Intern. Med., 56: 675, 1962.
124. Hagedorn, K.: A case of aleukemia myelosis with osteosclerosis and gout. Zeit. J. Klin. Med., 104: 124, 1926.
125. Hardin, B., Valentine, W. N., Follette, J. H. and Lawrence, J. S.: Studies on the sulf-hydryl content of human leukocytes and erythrocytes. Amer. J. Med. Sci., 228: 73, 1954.
126. Harris, C. E. and Pick, C. A.: Acute erythraemic myelosis. Canad. Med. Assn. J., 78: 198, 1958.
127. Hassler-Krauspe, F.: Biobachtungen über generoisierte knochenerkrankungen des kindes. Virch. Arch. J. path. Anat., 290: 193, 1933.
128. Hayes, D. M. and Spurr, C. L.: Use of phytohemagglutinin to stimulate hematopoiesis in humans. Blood, 27: 78, 1966.
129. Heath, C. W., Jr., and Moloney, W. C: The Philadelphia chromosome in an unusual case of myeloproliferative disease. Blood, 26: 471, 1965.
130. Heilmeyer, L.: Perniciöse Anämie" als initial phase einer akuten Erythroleukämie. Seh. Med. Woch. 80: 1122, 1950.
131. Heilmeyer, L. and Begemann, H.: Handbuch der Inneren Medizin., Berlin, Springer, 1951.
132. Heller, E. L., Lewisohn, M. G. and Palin, W. E.: Aleukemic myelosis. Amer. J. Path., 23: 327 1947.
133. Heller, P., Weinstein, II. G., West, M. and Zimmerman, H. J.: Enzymes in anemia: A study of abnormalities of several enzymes of carbohydrate metabolism in the plasma and erythrocytes in patients with anemia, with preliminary observations of bone marrow enzymes. Ann. Intern. Med., 53: 898, 1960.
134. Hennemann, H. H.: Die Erhohung der Glucose-6-phosphatdehydrogenase aktivität der erythrocyten und ihre Klinische Beuteihmg. Klin. Woch., 41: 1014,1963.
135. Hennemann, H. H., Kunz, G. and Gillert, K. E.: Symptomatische hämolytiche anämie mit positivem Coombs-test bei osteomyeloretikulose. Acta Haemat., 10: 260, 1953.
136. 12-binding proteins. Blood, 32: 305, 1968.
137. Heuck, G.: Zwei Fälle von Leukämie mit eigenthümlichen Blut-resp. Knockenmarks-befund. Vircnows Are, 76: 475, 1879.
138. Hickling, R. A.: Chronic non-leukemic myelosis. Quart, J. Med., 6: 253,1937.
139. Hickling, R. A.: Treatment of patients with myelosclerosis. Brit. Med. J., 2: 411, 1953.
140. Hickling, R. A.: Leukemia and related conditions and the blood-uric-acid. Lancet, 1: 175, 1958.
141. Hirsch, E. F.: Generalized osteosclerosis with chronic polycythemia vera. Arch. Path., 19: 91, 1935.
142. Hirschfeld, H.: Zur Kenntnis der atypischen myeloiden Leukämie. Berl. Klin. Wschr., 42: 1004, 1905.
143. Hirschfeld, H.: Die generalisierte aleukamische Myelose und ihre Stellung im System der leukamisehen Erkrankungen. Ztschr. Klin. Med., 80: 126,1914.
144. Hirschfeld, H., and Alexander, W.: Ein Visher Noch Nicht blubachteter Befund bei eineim Fall von acuter (Myeloider?) Leukaimie. Berl. Klin. Wschr., 39: 231, 1902.
145. Hittmair, A.: Megakaryocytenleukamie und osteomyelosklerose. Ein embertliches krank-bertsgesehen. Klin. Wschr., 23: 71, 1944.
146. Hoffbrand, A. V., Channarin, I., Kremenchuzky, S., Szur, L., Waters, A. H., and Mollin, D. L.: Megaloblastic anemia in myelosclerosis. Quart. J. Med., 37: 493, 1968.
147. Hoffman, A.: Aleukemie leukemia. Klin. Wschr., 5: 124, 1926.
148. Hooey, M. A., Crookston, J. H., and Squires, A. H.: Myeloproliferative disease complicated by megaloblastic anemia and hyper-uricemia. Canad. Med. Assn. J., 93: 935, 1965.
149. Huber, H., Lewis, S. M. and Szur, L.: Anämie und Gesamtmerge zirkulierender Erythrocyten bei osteomyelosklerose. Klin. Wschr., 43: 758, 1965.
150. Huff, R. L. Elmlinger, P. J., Garcia, J. F., Oda, J. M., Cockrell, M. C. and Lawrence, J. H.: Ferrokinctics in normal persons and in patients having various ervthropoietic disorders. J. Clin. Invest., 30: 1512, 1951.
151. 51-labelled cells. Brit. J. Haemat., 3: 320, 1957.
152. Hugonot, G. and Schier, R.: Splénomegalie myéloide megacaryocytaire amyélocythemique et tuberculose. Le Sang, 9: 933, 1935.
153. Hutt, M. S. R., Pinniger, J. L. and Wetherley-Mein, G.: The myeloproliferative disorders with special reference to myelofibrosis. Blood, 5:295,1953.
154. Ikkala, E., Rapola, J. and Kotilainen, M.: Polycythaemia vera and myelofibrosis. Scand. J. Haemat., 4: 453, 1967.
155. Jackson, H., Jr., Parker, F., Jr. and Lemon, H. M.: Agnogenic myeloid metaplasia of the spleen. New Eng. J. Med., 222: 985, 1940.
156. Jacobson, H. G., Fateh, H., Shapiro, J. H., Spaet, T. H. and Poppel, M. H.: Agnogenic myeloid metaplasia. Radiology, 72: 716, 1959.
157. Jandl, J. H., Greenberg, M. S., Yonemoto, R. H. and Castle, W. B.: Clinical determination of the sites of red cell sequestration in hemolytic anemias. J. Clin. Invest., 35: 842, 1956.
158. Jeannet, P.: Le syndrome de Di Gugiielmo. A propos de six observations. Helv. Med. Acta, 29: 231, 1962.
159. Jensen, M. K.: Splenectomy in myelofibrosis. Acta Med. Scand., 175: 533, 1964.
160. Jordan, H. E.: The histology of the bloodforming tissues of the urodele, Proteus anguineus. Amer. J. Anat., 51: 215, 1932.
161. Jordan, H. E.: The evolution of blood-forming tissues. Quart. Rev. Bid., 8: 58, 1933.
162. Jordan, H. E.: The transformation of adipose tissue to hemocytopoietic tissue. Anat. Rec., 59: 461, 1934.
163. Jordan, H. E.: Comparative Hematology, in Handbook of Hematology. ed. Downey, H., Paul B. Hoeber, Inc., New York, 1938, p. 703.
164. Jordan, H. E.: Extramedullary blood production. Physiol. Rev., 22: 375, 1942.
165. Jordan, H. E. and Scott, J. K.: Case of osteosclerosis with extramedullary hemopoiesis and leukemic blood reaction. Arch. Path., 32:895,1941.
166. Karaca, M. and Stefanini, M.: Studies on platelets. XXV. Chemical analysis of platelets from patients with congenital and acquired thrombocytopathy, with special reference to phospholipids. J. Lab. Clin. Med., 67: 229,1966.
167. Kennedy, B. J.: Effect of androgenic hormone on myelofibrosis. J.A.M.A., 182: 116, 1962.
168. Kerneis, J. P. and Savoie, J. C: L'ostéomyélosclérose et les réactions de la substance osseuse dans la splénomégalie myéloide de l'adulte. Le Sang, 24: 833, 1953.
169. Killmann, S. A.: Proliferative activity of blast cells in leukemia and myelofibrosis. Acta Med. Scand., 178: 263, 1965.
170. Killmann, S. A.: Myelofibrosis. Clin. Orthop., 52: 95, 1967.
171. King, J. E. and Ackerman, G. A.: Erythropoiesis in the bone marrow of the fetal rabbit. Anat. Rec, 157: 589, 1967.
172. Kistler, G. H.: Sequences of experimental infarction of the femur in rabbits. Arch. Surg., 29: 589,1934.
173. Klemperer, P.: The Spleen, in Handbook of Hematology. ed. Downey, H., Paul B. Hoeber, Inc., New York, 1938, p. 1589.
174. Knoll, W.: Die bluthiidung beim embryo, in Handbook d. allg. Hämatologie, ed. Hirschfeld and Hillman, Berlin I, pt. 1, 553, 1932.
175. Knoll, W.: Der Gang der Erythropoese beim menschlichen Embryo. Acta Haematol, 2: 369, 1949.
176. Knudtson, K. P., Evanger, A. E. and Stevens, A. R., Jr.: Standardization of the leukocyte alkaline phosphatase test. II. Report of clinical studies. Amer. J. Clin. Path., 42: 121, 1964.
177. Koler, R. D.: Prognosis in the myelofibrosismyelold metaplasia syndrome. Clin. Res. Proa, 5: 57, 1957.
178. Koler, R. D., Seaman, A. J., Osgood, E. E. and Vanbellinghem, P.: Myeloproliferative diseases. Diagnostic value of the leukocyte alkaline phosphatase test. Amer. J. Clin. Path., 30: 295, 1958.
179. Korpassy, B. and Kelemen, E.: Vaquez-Osler' sehe Krankheit-Panmyelose. Acta Haemat., 2: 110, 1949.
180. Korst, D. R., Clatanoff, D. V. and Schilling, R. F.: On myelofibrosis. A.M.A. Arch. Intern. Med., 97: 169, 1956.
181. Kough, R. H.: Idiopathic myelofibrosis with myeloid metaplasia of the spleen: a disease entity being recognized with increasing frequency. Med. Times, 94: 489, 1966.
182. Kraeysky, N. A. and Sacharoff M. P.: Au Sujet de la leucemie Dite osteosclerotique. Le Sang, 27:203,1956.
183. Krakoff, I. H.: Studies of uric acid biosynthesis in the chronic leukemias. Arth. Rheumat.,8: 772,1965.
184. Krantz, S. B.: Response of polycythemia vera marrow to erythropoietin in vitro. J. Lab. Clin. Med, 71:999,1968.
185. Krasso, H. and Nothnagel, H.: Atypische tuberkulöse (Gefiugeltuberkulose) bei myeloiseber Leukämie. Wien. Arch. F. Inn-Med., 11: 507, 1925.
186. Krauss, S.: Chronic myelocytic leukemia with features simulating myelofibrosis with myeloid metaplasia. Cancer, 19: 1321, 1966.
187. Krauss, S., Gilbert, H. S. and Wasserman, L. R.: Leukocyte histidine decarboxylase: Properties and activity in myeloproliferative disorders. Blood, 31: 699, 1968.
188. Krauss, S., Sokal, J. E. and Sandberg, A. A.: Comparison of Philadelphia chromosome-positive and negative patients with chronic myelocytic leukemia. Ann. Intern. Med., 61: 625, 1964.
189. Kunz, G.: Die funktronstorunb des lymphatischen gemebes als primäre eustehungsur-sache der extrameduüaren metaplasie und der osteomyeloskerose. Das Deutsche Ges-undhertswesen, 38: 1141, 1953.
190. Kurihara, M.: Uber das blutbildande gewebe im der dura mater des menschen und kanin-schens. Trans. Soc. Path. Jap., 25: 364, 1935.
191. Lang, F. J.: Myeloid metaplasia, in Handbook of Hematology, ed. by Downey, H., Paul B. Hoeber, Inc., New York, 1938, p. 2104.
192. 15-labeled glycine. Amer. J. Med., 15: 857, 1953.
193. Lawrence, J. H., Berlin, N. I. and Huff, R. L.: The nature and treatment of polycythemia. Medicine, 32: 323, 1953.
194. Lehndorff, H. and Zak, E.: Myeloide leukäemie im Greisenalter mit eigenartigen histologischen Befunden. Folia Haemat., 4: 6363, 1907.
195. Leigh, T. F., Corley, C. C, Jr., Huguley, C. M., Jr., and Rogers, J. V., Jr., Myelofibrosis: The general and radiologic findings in 25 proven cases. Amer. J. Roentgenol., 82: 183, 1959.
196. Leonard, B. J., Israels, M. C. B. and Wilkinson J. F.: Myelosclerosis: A clinicopathological study. Quart. J. Med., 26: 131, 1957.
197. 1chromosomes in two brothers. Blood, 30: 503, 1967.
198. Levin, W. C, Ritzmann, S. E. and Houston, E. W.: Letter to the editor. Blood, 32: 181, 1968.
199. Levinson, S. A. and Limarzi, L. R.: Agnogemc myeloid metaplasia of spleen. Amer. J. Clin. Path., 17: 449,1947.
200. Levitan, R., Diamond, H. D. and Craver, L. F.: Myeloid metaplasia in Hodgkin's disease. N.Y. State J. Med., 59: 2376, 1959.
201. Levy, J. M., Weill-Bousson, Mme., Stephan, F., Frühling, L. and Metzger, H.: Remarques au sujet de trois cas de myélose aleucémique mégacaryocytaire. Le Sang, 27: 351,1956.
202. Lewis, S. M. and Szur, L.: Malignant myelosclerosis. Brit. Med. J., 2: 472, 1963.
203. Lieberman, P. H., Rosvoll, R. V. and Ley, A. B.: Extramedullary myeloid tumors in primary myelofibrosis. Cancer, 18: 727, 1965.
204. Lievre, J. S. and Mallarme, J.: Anemie osteosclerotique. Bull. Soc. Med. Hop. Paris, 64: 1050, 1948.
205. Linman, J. W. and Bethell, F. H.: Agnogemc myeloid metaplasia. Amer. J. Med., 22: 107, 1957.
206. Long, R. S., Simmons, E. E. and Schenken, J. R.: Myeloid metaplasia with terminal leukemia. J.A.M.A., 152: 1619, 1953.
207. Lopas, H. and Josephson, A. M.: Myeloproliferative syndrome. A.M.A. Arch. Intern. Med., 114: 754,1964.
208. Louyot, P., Gaueher, A. and Benoit, P.: Terminal acute blastic transformation of a case of myeloid splenomegaly. Ann. Med. Nancy, 4: 1008,1965.
209. Lowman, R. M., Bloor, C. M. and Newcomb, A. W.: Roentgen manifestations of thoracic extramedullary hematopoiesis. Dis. Chest, 44: 154, 1963.
210. Lüdin, H.: Zur Klinik und Hämatologie der Erythromyelosen. Acta Haemat. 4: 321, 1950.
211. Lyndeboom, G. A.: lieber die sogenannte aleukämische megakaryocytare myelose. Acta Med. Scand., 96: 388, 1938.
212. Magill, G. B., Wroblewski, F. and LaDue, J. S.: Serum lactic dehydrogenase and serum transaminase in human leukemia. Blood, 14: 870, 1959.
213. Marchai, G. and Duhamel, G.: Sur une variété atypique de leueose aigué: La Leucémie a mégacaryocytes. Bull, et Med. de la Soc. Med. Desp. Hosp. de Paris, 69: 851,1953.
214. Marson, F. G. and Meynell, M. J.: Polycythaemia and myelosclerosis. Brit. Med. J., 1: 1113, 1952.
215. Maximow, A.: Experimentelle Untersuchungen zur postfötalen histogenase des myeloiden gewebes. Beitr. Z. Path. Anat., 41: 122, 1907.
216. Maximow, A.: Untersuchungen über Blut und Bindegewebe. I. Die frühesten Entwicklungstadien der Blut und Bindegewezellen beim Saügetier-Embryo, bis zum Anfang der Blutbildung in der leber. Arch. J. Mikr. Anat., 73: 444, 1909.
217. Maximow, A.: Relation of blood cells to connective tissue and endothelium. Physiol. Rev., 4: 533,1924.
218. Maximow, A.: Bindegewebe und Blutbildende Gewebe, in Handbuch der Mikroskopischen Anatomie der Mensehen, ed. by vonMollen-dorff, W., Springer, Berlin, 1927.
219. Mayer, G., Mayer, S. and Waitz, R.: Transitory antiplatelet anticoagulant and Hargraves cells in the course of osteomyelosclerosis (Fr). Acta Haemat., 32: 206, 1964.
220. McCabe, W. R, Bird, R. M. and McLaughlin, R. A.: Is primary hemorrhagie thrombocythemia a clinical myth? Ann. Intern. Med., 43: 182, 1955.
221. McCuskey, R. S.: Dynamic microscopic anatomy of the fetal liver III. Erythropoiesis. Anat. Rec, 161: 267,1968.
222. McMichael, J. and McNee, J. W.: Leucoerythroblastosis. Edinburgh Med. J. N.S. (IV), 48: 303, 1936.
223. Medoff, A. S. and Stickney, J. M.: Primary myelofibrosis with myeloid Metaplasia. Med. Clin. N. Amer., 40: 1125, 1956.
224. Merker, H.: The significance of cytochemical and cytogenetic findings in chronic granulocytic leukemiaand related diseases, in Current Research in Leukemia, ed. by Hayhoe, F. G. J., Cambridge University Press, Cambridge, 1965, p. 1.
225. Merskey, C: Chronic nonleukemic myelosis: Report of six cases. Arch. Intern. Med., 84: 277, 1949.
226. Metz, J. and Klein, H. R.: Observations on a case of erythremic myelosis. Ann. Inter. Med., 53: 207-15, 1960.
227. Meyer, E. and Heineke, A.: Ueber Blutbildung bei schweren Anämien und Leukämien. Deutsch. Arch. Klin. Med., 88: 435, 1907.
228. 12-binding. Acta Med. Scand., 181: 591, 1967.
229. Miller, J. F. A. P., Block, M. H., Rowlands, J. R., Jr. and Kind, P.: Effect of thymectomy on the hematopoietic organs of the opossum embryo. Proc. Soc. Biol. Med., 118: 916, 1965.
230. Minot, G. R. and Buckman, T. E.: Erythremia (polycythemia rubra vera). The development of anemia; the relation to leukemia; consideration of basal metabolism blood formation and destruction and fragility of the red cells. Amer. J. Med. Sci., 166: 469, 1923.
231. Minot, G. R., Buckman, T. E. and Isaacs, R.: Chronic myelogenous leukemia: Age incidence, duration and benefit derived from treatment. J.A.M.A., 82: 1489, 1924.
232. Mitus, W. J., Bergna, L. J., Mednicoff, I. B. and Dameshek, W.: Alkaline phosphatase of mature neutrophils in chronic forms of the myeloproliferative syndrome. Amer. J. Clin. Path., 30: 285, 1958.
233. Modan, B. and Lilienfeld, A. M.: Polycythemia vera and leukemia: The role of radiation treatment; A study of 1222 patients. Medicine, 44: 305, 1965.
234. Moeschlin, S.: Erythroblastosen, Erythroleukämien, und Erythroblastämien. Folia Haemat., 64: 262, 1940.
235. Moeschlin, S.: Spleen Puncture, translated by Piney, A., Grune and Stratton, New York, 1951.
236. Morrow, L. B. and Anderson, R. E.: Active tuberculosis in leukemia, malignant lym-phoma and myelofibrosis. Arch. Path., 79: 484, 1965.
237. Mozer, J. J.: Les ostéoscléroses diffuses. Les anémies ostéosclérotiques. Rev. Med. de la Suisse Rom., 47: 802,1927.
238. Mulcahy, F.: Bone changes in myelosclerosis. Proc. Roy. Soc. Med. 50: 100,1957.
239. Nakai, G. S., Craddock, C. G. and Figueroa, W. G.: Agnogenic myeloid metaplasia. A survey of 29 cases and a review of the literature. Ann. Intern. Med., 57: 419, 1962.
240. Nathan, D. G. and Berlin, N. I.: Studies of the production and life span of erythrocytes in myeloid metaplasia. Blood, 14: 668, 1959.
241. Nauwerck and Moritz: Atypische Leukämie mit Osteosklerose. Deutsch. Arch. J. Klin. Med., 84: 558,1905.
242. Nelson, M. G.: The association of physicians of Great Britain and Ireland, 1952, 46th Annual General Meeting. Quart. J. Med., 21: 464, 1952.
243. Nettleship, A.: Bone marrow changes produced by specific antibodies. Amer. J. Path., 18: 689, 1942.
244. Neumann, E.: Ueber die bedeutung des knochemarks für die blutbildung. Zentr. Med. Wiss., 6: 689,1868.
245. Niles, N. R., Koler, R. D., Johnson, R. L., Smith, D. D. and Dunlap, W. J.: Myeloproliferative diseases; clinical and pathological study of 69 cases. Amer. J. Clin. Path., 31: 222,1959.
246. Nowell, P. C. and Hungerford, D. A.: A minute chromosome in human chronic granulo-cytic leukemia. Science, 132: 1497, 1960.
247. Nowell, P. C. and Hungerford, D. A.: Chromosome studies in human leukemia. IV. Myeloproliferative syndrome and other atypical myeloid disorders. J. Nat. Cancer Inst., 29: 911,1962.
248. Nowell, P. C, and Hungerford, D. A.: Chromosome changes in human leukemia and a tentative assessment of their significance. Ann. N.Y. Acad. Sci., 113: 654, 1964.
249. Oechslin, R. J.: Osteomyelosklerose und skelett. Acta Haemat., 16: 214, 1956.
250. Oesterlin, E.: Ein fall kombinierter knochen bluterkranbung. Virch. Arch. J. Path., 247: 589, 1923.
251. 59). Klin. Wschr., 42: 483, 1964.
252. Oishi, N., Swisher, S. N., Stormont, J. M. and Schwartz, S. I.: Portal hypertension in myeloid metaplasia. Arch. Surg., 81: 80, 1960.
253. Oishi, N., Swisher, S. N. and Troup, S. B.: Busulfan therapy in myeloid metaplasia. Blood, 15: 863, 1960.
254. Omura, K. and Osogoe, B.: Saponin induced colonization of the bone marrow elements in foreign organs in rabbits. Anat. Rec, 110: 289, 1951.
255. Ozer, F. L., Truax, W. E., Miersch, D. C. and Levin, W. C: Primary hemorrhagic throm-bocythemia. Amer. J. Med., 28: 807, 1960.
256. Padeh, B., Bianu, G. and Schaki, R.: Cytogenetic studies in proliferative disorders. Israel J. Med. Sci., 1. 795,1965.
257. Paloheimo, J. A. and Ikkala, E.: Serum lactic dehydrogenase activity and isoenzyme patterns in some haematological diseases. Acta Med. Scand., 177: 155,1965.
258. Paolino, W.: The syndrome of the pseudoleukemic (Pseudoerythremic) myelosis. Acta Haemat., 2: 86,1949.
259. Papageorgiou, V. A.: Die knocheniveränderungen der myelofibrosen und osteomyelofi-brosen. Acta Haemat., 28: 201, 1962.
260. Pawelski, S., Maj., St. and Topolska, P.: Chromosomal abnormalities of spleen cells in osteomyelosclerosis. Acta Haemat., 38: 397,1967.
261. Peace, R. J.: Myelonecrosis, extramedullary myelopoiesis and leukoerythroblastosis. Amer. J. Path., 29: 1029, 1953.
262. Pengelly, C. D. R.: Stimulation of red-cell production in myelofibrosis with Prednisone. Postgrad. Med. J., 40: 30,1964.
263. Perkins, J., Israels, M. C. G. and Wilkinson, J. F.: Polycythaemiavera; Clinical studies on a series of 127 patients managed without radiation therapy. Quart. J. Med., 33: 499, 1964.
264. Pettigrew, J. D. and Ward, H. P.: Correlation of radiologic, histologic and clinical findings in agnogenic myeloid metaplasia. Radiology, 93: 541, 1969.
265. Pfeiffer, C. A. and Gardner, W. U.: Inhibition of estrogenic effects on skeleton by testosterone injections. Proc. Soc. Exp. Biol. Med., 38: 599, 1938.
266. Pitcock, J. A., Reinhard, E. H., Justus, B. W. and Mendelsohn, R. S.: A clinical and pathological study of 70 cases of myelofibrosis. Ann. Intern. Med., 57: 73, 1962.
267. Port, M. and Hyman, J. B.: Myeloid metaplasia as a result of chronic benzene intoxication. N.Y. J. Med., 65: 2260, 1965.
268. Prentice, T. C. and Mirand, E. A.: Effect of acute liver damage plus hypoxia on plasma erythropoietin content. Proc. Soc. Exp. Biol. Med., 95: 231, 1957.
269. Rathery, F. M.: Splénomégalic du type myéloide sans myélocythémie. Compt. Rend. Soc. Biol., 54: 138,1902.
270. Rawson, R., Parker, F., Jr. and Jackson, H., Jr.: Industrial solvents as possible etiologic agents in myeloid metaplasia. Science, 93: 541, 1941.
271. Reich, C. and Rumsey, W., Jr.: Agnogenic myeloid metaplasia of the spleen. J.A.M.A., 118: 120, 1942.
272. Reznikoff, P., Foot, N. C. and Bethea, J. M.: Etiologic and pathologic factors in polycy themia vera. Amer. J. Med. Sci., 189: 753, 1935.
273. Rising, J. D. and Dclp, M.: Edema progressing from the lower extremities to the trunk and upper extremities. J. Kans. Med. Soc, 66: 509, 1965.
274. Roath, Stuart and Israels, M. C. G.: Chronic Erythraemic Myelosis. Lancet II (7266): 1140-43, 1962.
275. Robson, H. N.: Myelosclerosis: A study of a condition also known as myelofibrosis, aleu-kaemic myelosis, agnogenic myeloid metaplasia, and other titles. Aust. Ann. Med., 2: 170, 1953.
276. Rohr, K.: Myelofibrose und osteomyelsklerose (osteomyeloretikulosc-syndrom). Acta Haemal., 15: 209, 1956.
277. Rohr, K.: Der Formenkreis des Myelofibrosesyndroms. Acta Haemat., 20: 63, 1958.
278. Rolf, H.: Zur Anaemia leuco-erythroblastic mit Myelosklerosis (Tvp. Vaughan). Klin. Wschr., 27: 641, 1949.
279. Rosenbaum, D. L., Murphy, G. W. and Swisher, S. N.: Hemodynamic studies of the portal circulation in myeloid metaplasia. Amer. J. Med., 41: 360, 1966.
280. Rosenberg, H. S. and Taylor, F. M.: The myeloproliferative syndrome in children. J. Pediat., 52: 407, 1958.
281. Rosenthal, D. S. and Moloney, W. C: Myeloid metaplasia: A study of 98 cases. Postgrad. Med., 45: 136, 1969.
282. Rosenthal, M. C: Extramedullary hemapoiesis. Myeloid metaplasia. Bull. New Eng. Med. Center, 12: 154, 1950.
283. Rosenthal, N. and Erf, L. A.: Clinical observations on osteopetrosis and myelofibrosis. Arch. Intern. Med., 71: 793, 1943.
284. Ruebner, B.: Myelosclerosis with serosal myeloid metaplasia and fatal liver involvement. Ann. Intern. Med., 53: 1075, 1960.
285. Rushton, K. M.: Otosclerosis associated with disease of the haemopoietic system. J. Laryng., 78: 612, 1964.
286. Saeerdotti, C. and Frattin, G.: Ueber die heteroplastische Knochenbildung. Experimentelle Untersuchungen, Virch. Arch., 168: 431, 1902.
287. Samuelsson, S. M., Killander, A., Werner, I. and Stenkvist, B.: Myelofibrosis associated with tuberculous lymphadenitis. Acta. Med. Scand., 179, Suppl. 445: 326, 1966.
288. Sandberg, A. A., Ishihara, T. and Crosswhite, L. H.: Group-C trisomy in myeloid metaplasia with possible leukemia. Blood, 24: 716, 1964.
289. Sandkühler, St. and Stodtmeister, R.: Knochenmarkatrophic und Knochenmarkfibrose, Dtsch. Med. Wschr., 76: 1431, 1951.
290. Sandusky, W. R., Leavell, B. S. and Benjamin, B. I.: Splenectomy: indications and results in hematologic disorders. Ann. Surg., 159: 695, 1964.
291. Sass. M. D. Vorsanger, E. and Spear, P. W.: Enzyme activity as an indicator of red cell age. Clinic. Chim. Acta, 10: 21, 1964.
292. Sawada, K.: Statistical studies on autopsy cases in Japan excluding malignant tumors from 1946 to 1955 inclusive, as compared with Eastern and Western parts of Japan. Oshia Univ. Med. J., 11: 1075. 1959.
293. Say, B. and Berkel, I.: Idiopathic myelofibrosis in an infant. J. Pediat., 64: 580, 1964.
294. Scharrer, E.: The histology of the meningeal myeloid tissue in the ganoids amia and Lepisosteus. Anat. Rec, 88: 291, 1944.
295. Schmidt, D., Ward, H. P. and Block, M. H.: Agnogenic myeloid metaplasia and the Budd-Chiari syndrome. In Myeloproliferative Syndromes of Animals and Man, ed. by Clarke, W. J., Howard, E. B. and Hackett, P. C, USAES Division of Technical Information, Oak Ridge, Tenn, 1970, p. 346.
296. Schmidt, M. B.: Handbuch der speziellen pathologischen Anatomie und Histologie, ed. by Henke, F. and Lubarsch, O., Springer, Berlin. 1937. Pt. 3, 76.
297. Schulze, E., Franke, R. and Koch, E.: Über myeloisehe metaplasie als klinische syndrom. Deut. Arch. J. Klin. Med., 199: 369, 1952.
298. Schwartz, S. O. and Critchlow, J.: Erythremic myelosis (Di Guglielmo's disease). Blood, 7: 765,1952.
299. Schwarz, E.: Extramedullary megakaryoeytosis in chronic myelosis. Amer. J. Clin. Path., 24: 629, 1954.
300. Selye, H., Gabbiani, G. and Tuchweber, B.: An experimental model of osteomyelosclero-sis. Acta. Haemat., 29: 51, 1963.
301. Shaldon, S. and Sherlock, S.: Portal hypertension in the myeloproliferative syndrome and the reticuloses. Amer. J. Med., 32: 758, 1962.
302. Silberberg, M. and Silberberg, R,.: Action of estrogens on skeletal tissues of immature guinea pigs. Arch. Path., 28: 340, 1939.
303. Silver, R. T., Jenkins, D. E., Jr. and Engle, R. L.: Use of testosterone and bulsulfan in the treatment of myelofibrosis with myeloid metaplasia. Blood, 23: 341, 1964.
304. Silverstein, M. N.: Primary or hemorrhagic thrombocythemia. Arch. Intern. Med., 122: 18, 1968.
305. Silverstein, M. N., Gomes, M. R., ReMine, W. H. and Elveback, L. R.: Agnogenic myeloid metaplasia: natural history and treatment. Arch. Intern. Med., 120: 546, 1967.
306. Silverstein, M. N. and Linman, J. W.: Causes of death in agnogenic myeloid metaplasia. Mayo Clin. Proc, 44: 36, 1969.
307. Sippy, B. W.: Splenic pseudoleukaemia (Anaemia splenica, Splenomegalie Primitive). Amer. J. Med. Sci., 118: 428, 1899.
308. Skinner, H. C. and Sophean, L. S.: Agnogenic myeloid metaplasia of the spleen: Follow-up after splenectomy. J. Intern. Col. Surg., 15: 343, 1951.
309. Smyth, C. J., Cotterman, C. W. and Freyberg, R. H.: The genetics of gout and hyperuri-cemia-An analysis of 19 families. J. Clin. Invest., 27: 749, 1948.
310. Sorsdahl, O. S, Taylor, P. E. and Noyes, W. D.: Extramedullary hematopoiesis, me-diastinal masses, and spinal cord compression. J.A.M.A., 189: 343, 1964.
311. Spickard, A.: Multiple myeloma with myelofibrosis and with polycythemia vera: further evidence of a relationship between the myeloproliferative disorders. Bull. Johns Hopkins Hosp., 107: 234. 1960.
312. Steinberg, B. and Huffond, V.: Development of bone marrow in adult animals. Arch. Path., 43: 117, 1947.
313. Stephens, D. J. and Bredeck, J. V.: Aleukemic myelosis with osteosclerosis. Ann. Intern. Med., 6: 1087, 1933.
314. Stodtmeister, R., Becker, H., Cronkite, E. P., Fliedner, T. M. and Messner, H.: Experimentelle Knochenmarkfibrose in Ratten nach subletaler GanzkörperRontgenbestrahlung und Knochenmarktransfusionen also Modell der menschlichen Myelofibrose. Schweiz, med. Wschr., 98: 1671, 1968.
315. Stodtmeister, R. and Sandkühler, St.: Knochenmarkatrophie und Knochenmarkfibrose. Dtsch. med. Wschr., 76: 1431,1951.
316. Stodtmeister, R., Sandkühler, St. and Lauer, A.: Osteosklerose und Knochensmarksfibrose. Thieme, Stuttgart. 1953.
317. Sussman, M. L.: Myelosclerosis with leukoerythroblastic anemia. Amer. J. Roentgenol., 57: 313, 1947.
318. Szur, L. and Smith, M. D.: Red cell production and destruction in myelosclerosis. Brit. J. Haemat., 7: 147, 1961.
319. Talbott, J. H.: Gout and blood dyscrasias. Medicine, 38: 173, 1959.
320. Tanzer, J., Najean, Y., Jacquillat, C, Ripavet, J. and Chome, J.: Fibrose médullaire et erythroblastose splénique dans la leucémie myéloide chronique. Nouv. Rev. Franc. d'Hemat., 7: 801, 1967.
321. Taylor, H. E. and Simpson, W. W.: Bone marrow fibrosis developing in aleukemic myelosis. Blood, 6: 348, 1951.
322. Taylor, H. E. and Smith, R. P.: Marrow sclerosis associated with massive myeloid splenomegaly. Arch. Path., 31: 803, 1941.
323. Thiel, G. and Downey, EL: The development of the mammalian spleen, with special reference to its hematopoietic activity. Amer. J.Anat., 23:279,1921.
324. Tough, I. M., Court-Brown, W. M., Baikie, A. G., Buckton, K. E., Harnden, D. G., Jacobs, P. A., King, M. J. and McBride, J. A.: Cytogenetic studies in chronic myeloid leukemia and acute leukemia associated with mongolism. Lancet, 1: 411, 1961.
325. Tough I. M., Court-Brown, W. M., Baikie, A. G., Buckton, K. E., Harnden, D. G., Jacobs. P. A. and Williams, J. A.: Chronic myeloid leukemia: cytogenetic studies before and after splenic irradiation. Lancet, 2: 115, 1962.
326. Türk, W.: Beitrage zue kenntnis des symptomenbildes polyzythämie mit milztumor und zyanose. Wein Klin. Wschr., 17: 153, 1904.
327. Ultmann, J. E.: The role of the spleen in the hemolytic anemia of cancer patients. Cancer Res., 18: 959, 1958.
328. Valentine, W. M., Beck, W. S., Follette, J. H., Mills, H. and Lawrence, J. S.: Biochemical studies in chronic myelocytic leukemia, polycythemia vera, and other idiopathic myeloproliferative disorders. Blood, 7: 959, 1952.
329. VanDyke, D., Lawrence, J. H. and Anger, II. P.: Whole-body marrow distribution studies in polycythemia vera, in Myeloproliferative Disorders of Animals and Man, ed. by Clarke, W. J. Howard. E. B. and Hackett, P. L., USAEC Division of Technical Information, Oak Ridge, Tenn., 1970, p. 721.
330. Vaughan, J. M.: Leuco-ervthroblastic anemia. J. Path. Bact, 42: 541, 1936.
331. Vaughan, J. M. and Harrison, C. V.: Leucoerythroblastic anemia and myelosclerosis. J. Path. Bact, 48: 339, 1939.
332. Videbaek, A.: Splenectomy in reticulosis, fibrosis and sclerosis of the bone marrow. Acta Haemat., 15: 235, 1956.
333. Videbaek, A. and Poulsen, H.: Myelofibrosis complicated by lymphogenous leukaemia. Acta Haemat., 17: 250, 1957.
334. Vogt, A.: Osteosklerose bei Blutkrankheiten die osteosklerotische Anämie vom typus M. B. Schmidt und die osteosklerotische Leukämie. Fortschr. a.d. Geb. Röntgen., 71: 697, 1949.
335. VonJaksch, R.: Multiple Periostaffection und an myelogene leukämie mahnander Blutbefund. Prog. Med. Wschr., 26: 2, 1901.
336. Waechter, R., Meyer-Burg, and Neubauer, F. W.: Zur Problematik der akuten Erythroblastose des Erwachsenen (Morbus DiGuglielmo). Deut. Med. Wschr., 94: 2421, 1969.
337. Waitz, R.: La moelle osseuse dans les splénomégalies myélocytaires, érythroblastiques et mégacaryocytaires de l'adulte. Le Sang., 24: 820, 1953.
338. Walker, R. L, Herion, J. C, Herring, W. B. and Palmer, J. G.: Leukocyte kinetics in hematologic disorders studied by DNA-phosphorus labeling. Blood, 28: 795, 1964.
339. Ward, H. P. and Block, M. H.: Myeloid metaplasia: a reevaluation, in Myeloproliferative Disorders of Animals and Man, ed. by Clarke. W. J., Howard, E. B. and Hackett, P. L. USAEC Division of Technical Information, Oak Ridge, Tenn., 1970, p. 609.
340. Ward. H. P., Kurnick, J. E. and Pisarczyk, M. J.: Serum level of erythropoietin in anemias associated with chronic infection, malignancy and primary hematopoietic disease. J. Clin. Invest., in press.
341. Ward, H. P., Pickett, J. C. and Gordon, B.: Serum levels of erythropoietin in rheumatoid arthritis. J. Lab. Clin. Med., 74: 93, 1969.
342. Wasserman, L. R.: Polycythemia vera-its course and treatment: Relation to myeloid metaplasia and leukemia. Bull. N.Y. Acad. Med., 30: 343, 1954.
343. Weber, F. P.: Polycythaemia, erythrocytosis and erythraemia. Quart. J. Med., 2: 85, 1908.
344. Weil, P. E., Chevallier, P. and Sée, G.: Splénomégalie myéloide megacaryocytaire amyélocythémique. Le Sang, 7: 773, 1933.
345. Weil, P. E. and Clerc, A.: Splénomegálie chronique avec anémie et reáction myéloïde du sang. Semaine Med., 22: 373, 1902.
346. Weil, P. E., Isch-Wall, P., Perlés, S. and Seemama, J.: Un cas de splénomégalie myéloïde megacaryocytaire. Le Sang, 10: 797, 1936.
347. Weil, P. E., Perles, S.: La maladie erythroblastique de l'adulte. Ann. de Med., 43: 5, 1938.
348. Weiss, L.: An electron microscopic study of the vascular sinuses of the bone marrow of the rabbit. Bull. Johns Hopkins Hosp., 108: 171, 1961.
349. Wellington, M. S.: Association of cyanoco balamin deficiency with myeloproliferative states: Report of three cases. Amer. J. Med. Sci., 239: 750, 1960.
350. Werzberg, A.: Neue experimentelle beitrage zur frage der myeloiden metaplasia. Virch. Arch., 204: 272, 1911.
351. Whitby, L.: The significance of megakaryocytes in the peripheral circulation. Blood, 3: 934, 1948.
352. Willoughby, M. L. N., and Addis, G. S.: DiGuglielmo's syndrome: A report of two cases. Scottish Med. J., 7: 218, 1962.
353. Winkelstein, A., Goldberg, L. S., Tishkoff, G. H. and Sparkes, R. S.: Leukocyte alkaline phosphatase and the Philadelphia chromosome. Arch. Intern. Med., 119: 291, 1967.
354. Wintrobe, M.: Clinical Hematology, Ed. 5, Lea and Febiger, Philadelphia, Penn., 1961.
355. Wolf, C: Über einen Fall von osteosklerotischer Pseudoleukämie. Beitrag zur Frage der Osteosklerosen. Beitr. z. path. anat. u.z. Path.,89: 151, 1932.
356. Wyatt, J. P. and Sommers, S. C: Chronic marrow failure, myelosclerosis, and extra-medullary hematopoiesis. Blood, 6: 329, 1950.
357. Yu, T. F.: Secondary gout associated with myeloproliferative diseases. Arthritis and Rheum., 8: 765, 1965.
358. Zambernard, J., Block, M., Vatter, A. and Trenner, L.: An adaptation of methacrylate embedding for routine histopathologic use. Blood, 33:444. 1969.
359. Zamboni, L. and Pease, D. C: The vascular bed of red bone marrow. J. Ultrastr. Res., 5: 65, 1961.